Market Research

Brain Cancer Diagnostics Market (Diagnostic Technique: Imaging Techniques, Tissue Sampling/Biopsy, Molecular Diagnostics, and Others; Brain Cancer Type: Gliomas, Meningiomas, Pituitary Tumors, and others) - Global Industry Analysis, Size, Share, Growth, T

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 180 Pages Transparency Market Research Pvt. Ltd. November, 2023 TNPR18404466
Best Price Guarantee
Price from $5,795
Length 180 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date November, 2023
SKU TNPR18404466

Brain Cancer Diagnostics Market (Diagnostic Technique: Imaging Techniques, Tissue Sampling/Biopsy, Molecular Diagnostics, and Others; Brain Cancer Type: Gliomas, Meningiomas, Pituitary Tumors, and others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031


Brain Cancer Diagnostics Market – Scope of Report

TMR’s report on the global brain cancer diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global brain cancer diagnostics market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global brain cancer diagnostics market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the brain cancer diagnostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global brain cancer diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global brain cancer diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global brain cancer diagnostics market.

The report delves into the competitive landscape of the global brain cancer diagnostics market. Key players operating in the global brain cancer diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global brain cancer diagnostics market profiled in this report.

Key Questions Answered in Global brain cancer diagnostics Market Report
  • What is the sales/revenue generated by brain cancer diagnostics across all regions during the forecast period?
  • What are the opportunities in the global brain cancer diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Brain Cancer Diagnostics Market – Research Objectives and Research Approach

The comprehensive report on the global brain cancer diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global brain cancer diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global brain cancer diagnostics market.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Brain Cancer Diagnostics Market
4. Market Overview
4.1. Introduction
  4.1.1. Product Definition
  4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
  4.3.1. Drivers
  4.3.2. Restraints
  4.3.3. Opportunities
4.4. Global Brain Cancer Diagnostics Market Analysis and Forecasts, 2023–2031
5. Key Insights
5.1. Brain Tumor Epidemiology
5.2. Current Trends in Diagnostic and Therapeutic Imaging of Brain Tumors
5.3. Technological advancements in cancer diagnostics
5.4. COVID-19 Impact Analysis
6. Global Brain Cancer Diagnostics Market Analysis and Forecasts, by Diagnostic Technique
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Diagnostic Technique, 2023–2031
  6.3.1. Imaging Techniques
6.3.1.1. Magnetic Resonance Imaging (MRI)
6.3.1.2. Computed Tomography (CT) Scan
6.3.1.3. PET Scan or PET-CT Scan
6.3.1.4. (SPECT) Scan
  6.3.2. Tissue Sampling/Biopsy
  6.3.3. Molecular Diagnostics
  6.3.4. Others
6.4. Market Attractiveness Analysis, by Diagnostic Technique
7. Global Brain Cancer Diagnostics Market Analysis and Forecasts, by Brain Cancer Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Brain Cancer Type, 2023–2031
  7.3.1. Gliomas
  7.3.2. Meningiomas
  7.3.3. Pituitary Tumors
  7.3.4. Others
7.4. Market Attractiveness Analysis, by Brain Cancer Type
8. Global Brain Cancer Diagnostics Market Analysis and Forecasts, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2023–2031
  8.3.1. Hospitals
  8.3.2. Diagnostic Laboratories
  8.3.3. Cancer Hospitals/Centers
8.4. Market Attractiveness Analysis, by End-user
9. Global Brain Cancer Diagnostics Market Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
  9.2.1. North America
  9.2.2. Europe
  9.2.3. Asia Pacific
  9.2.4. Latin America
  9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Brain Cancer Diagnostics Market Analysis and Forecast
10.1. Introduction
  10.1.1. Key Findings
10.2. Market Value Forecast, by Diagnostic Technique, 2023–2031
  10.2.1. Imaging Techniques
10.2.1.1. Magnetic Resonance Imaging (MRI)
10.2.1.2. Computed Tomography (CT) Scan
10.2.1.3. PET Scan or PET-CT Scan
10.2.1.4. (SPECT) Scan
  10.2.2. Tissue Sampling/Biopsy
  10.2.3. Molecular Diagnostics
  10.2.4. Others
10.3. Market Value Forecast, by Brain Cancer Type, 2023–2031
  10.3.1. Gliomas
  10.3.2. Meningiomas
  10.3.3. Pituitary Tumors
  10.3.4. Others
10.4. Market Value Forecast, by End-user, 2023–2031
  10.4.1. Hospitals
  10.4.2. Diagnostic Laboratories
  10.4.3. Cancer Hospitals/Centers
10.5. Market Value Forecast, by Country, 2023–2031
  10.5.1. U.S.
  10.5.2. Canada
10.6. Market Attractiveness Analysis
  10.6.1. By Diagnostic Technique
  10.6.2. By Brain Cancer Type
  10.6.3. By End-user
  10.6.4. By Country
11. Europe Brain Cancer Diagnostics Market Analysis and Forecast
11.1. Introduction
  11.1.1. Key Findings
11.2. Market Value Forecast, by Diagnostic Technique, 2023–2031
  11.2.1. Imaging Techniques
11.2.1.1. Magnetic Resonance Imaging (MRI)
11.2.1.2. Computed Tomography (CT) Scan
11.2.1.3. PET Scan or PET-CT Scan
11.2.1.4. (SPECT) Scan
  11.2.2. Tissue Sampling/Biopsy
  11.2.3. Molecular Diagnostics
  11.2.4. Others
11.3. Market Value Forecast, by Brain Cancer Type, 2023–2031
  11.3.1. Gliomas
  11.3.2. Meningiomas
  11.3.3. Pituitary Tumors
  11.3.4. Others
11.4. Market Value Forecast, by End-user, 2023–2031
  11.4.1. Hospitals
  11.4.2. Diagnostic Laboratories
  11.4.3. Cancer Hospitals/Centers
11.5. Market Value Forecast, by Country/Sub-region, 2023–2031
  11.5.1. Germany
  11.5.2. U.K.
  11.5.3. France
  11.5.4. Italy
  11.5.5. Spain
  11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
  11.6.1. By Diagnostic Technique
  11.6.2. By Brain Cancer Type
  11.6.3. By End-user
  11.6.4. By Country/Sub-region
12. Asia Pacific Brain Cancer Diagnostics Market Analysis and Forecast
12.1. Introduction
  12.1.1. Key Findings
12.2. Market Value Forecast, by Diagnostic Technique, 2023–2031
  12.2.1. Imaging Techniques
12.2.1.1. Magnetic Resonance Imaging (MRI)
12.2.1.2. Computed Tomography (CT) Scan
12.2.1.3. PET Scan or PET-CT Scan
12.2.1.4. (SPECT) Scan
  12.2.2. Tissue Sampling/Biopsy
  12.2.3. Molecular Diagnostics
  12.2.4. Others
12.3. Market Value Forecast, by Brain Cancer Type, 2023–2031
  12.3.1. Gliomas
  12.3.2. Meningiomas
  12.3.3. Pituitary Tumors
  12.3.4. Others
12.4. Market Value Forecast, by End-user, 2023–2031
  12.4.1. Hospitals
  12.4.2. Diagnostic Laboratories
  12.4.3. Cancer Hospitals/Centers
12.5. Market Value Forecast, by Country/Sub-region, 2023–2031
  12.5.1. China
  12.5.2. India
  12.5.3. Japan
  12.5.4. Australia & New Zealand
  12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
  12.6.1. By Diagnostic Technique
  12.6.2. By Brain Cancer Type
  12.6.3. By End-user
  12.6.4. By Country/Sub-region
13. Latin America Brain Cancer Diagnostics Market Analysis and Forecast
13.1. Introduction
  13.1.1. Key Findings
13.2. Market Value Forecast, by Diagnostic Technique, 2023–2031
  13.2.1. Imaging Techniques
13.2.1.1. Magnetic Resonance Imaging (MRI)
13.2.1.2. Computed Tomography (CT) Scan
13.2.1.3. PET Scan or PET-CT Scan
13.2.1.4. (SPECT) Scan
  13.2.2. Tissue Sampling/Biopsy
  13.2.3. Molecular Diagnostics
  13.2.4. Others
13.3. Market Value Forecast, by Brain Cancer Type, 2023–2031
  13.3.1. Gliomas
  13.3.2. Meningiomas
  13.3.3. Pituitary Tumors
  13.3.4. Others
13.4. Market Value Forecast, by End-user, 2023–2031
  13.4.1. Hospitals
  13.4.2. Diagnostic Laboratories
  13.4.3. Cancer Hospitals/Centers
13.5. Market Value Forecast, by Country/Sub-region, 2023–2031
  13.5.1. Brazil
  13.5.2. Mexico
  13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
  13.6.1. By Diagnostic Technique
  13.6.2. By Brain Cancer Type
  13.6.3. By End-user
  13.6.4. By Country/Sub-region
14. Middle East & Africa Brain Cancer Diagnostics Market Analysis and Forecast
14.1. Introduction
  14.1.1. Key Findings
14.2. Market Value Forecast, by Diagnostic Technique, 2023–2031
  14.2.1. Imaging Techniques
14.2.1.1. Magnetic Resonance Imaging (MRI)
14.2.1.2. Computed Tomography (CT) Scan
14.2.1.3. PET Scan or PET-CT Scan
14.2.1.4. (SPECT) Scan
  14.2.2. Tissue Sampling/Biopsy
  14.2.3. Molecular Diagnostics
  14.2.4. Others
14.3. Market Value Forecast, by Brain Cancer Type, 2023–2031
  14.3.1. Gliomas
  14.3.2. Meningiomas
  14.3.3. Pituitary Tumors
  14.3.4. Others
14.4. Market Value Forecast, by End-user, 2023–2031
  14.4.1. Hospitals
  14.4.2. Diagnostic Laboratories
  14.4.3. Cancer Hospitals/Centers
14.5. Market Value Forecast, by Country/Sub-region, 2023–2031
  14.5.1. GCC Countries
  14.5.2. South Africa
  14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
  14.6.1. By Diagnostic Technique
  14.6.2. By Brain Cancer Type
  14.6.3. By End-user
  14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis By Company (2021)
15.3. Company Profiles
  15.3.1. GE Healthcare
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Strategic Overview
15.3.1.5. SWOT Analysis
  15.3.2. Siemens Healthineers
15.3.2.1. Company Overview
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. Strategic Overview
15.3.2.5. SWOT Analysis
  15.3.3. Philips Healthcare
15.3.3.1. Company Overview
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. Strategic Overview
15.3.3.5. SWOT Analysis
  15.3.4. Thermo Fisher Scientific
15.3.4.1. Company Overview
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. Strategic Overview
15.3.4.5. SWOT Analysis
  15.3.5. Roche Diagnostics
15.3.5.1. Company Overview
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. Strategic Overview
15.3.5.5. SWOT Analysis
  15.3.6. Abbott Laboratories
15.3.6.1. Company Overview
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. Strategic Overview
15.3.6.5. SWOT Analysis
  15.3.7. Illumina, Inc.
15.3.7.1. Company Overview
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. Strategic Overview
15.3.7.5. SWOT Analysis
  15.3.8. Hologic, Inc.
15.3.8.1. Company Overview
15.3.8.2. Financial Overview
15.3.8.3. Product Portfolio
15.3.8.4. Strategic Overview
15.3.8.5. SWOT Analysis
  15.3.9. Agilent Technologies
15.3.9.1. Company Overview
15.3.9.2. Financial Overview
15.3.9.3. Product Portfolio
15.3.9.4. Strategic Overview
15.3.9.5. SWOT Analysis
  15.3.10. Bio-Rad Laboratories
15.3.10.1. Company Overview
15.3.10.2. Financial Overview
15.3.10.3. Product Portfolio
15.3.10.4. Strategic Overview
15.3.10.5. SWOT Analysis

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings